Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours?

Background Bone mineral density (BMD) is influenced by multiple factors. Recent studies have highlighted a possible relationship between serotonin and BMD. Patients with neuroendocrine tumours (NETs) frequently have elevated urinary 5-hydroxy-indoleacetic acid (5-HIAA) levels, a serotonin metabolite...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Gupta, P, Grozinsky-Glasberg, S, Drake, WM, Akker, SA, Perry, L, Grossman, AB, Druce, MR
Formaat: Journal article
Taal:English
Gepubliceerd in: 2014